COMMUNITY ACQUIRED BACTERIAL PNEUMONIA (CABP) TREATMENT DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market, By Drug Class (Pleuromutilin Antibiotic, Cephalosporin, Glycylcycline, Oxazolidinone, Ketolide, Others), By Dose Form (Solution, Tablet), By Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In: 30 Apr, 2026
Code: CMI4269
Page number: 168
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Class
  - Market Snippet, By Dose Form
  - Market Snippet, By Route of Administration
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Reimbursement Scenario
- Epidemiology
- Pest Analysis
- Regulatory Scenario
- New Product Launches
- Collaborations and Agreements
- Market Trends
Global Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market, By Drug Class, 2021 – 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Pleuromutilin Antibiotic
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Cephalosporin
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Glycylcycline
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Oxazolidinone
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Ketolide
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Global Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market, By Dose Form, 2021 – 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Solution
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Tablet
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Global Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market, By Route of Administration, 2021 – 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Intravenous
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Global Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market, By Distribution Channel, 2021 – 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Global Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market, By Region, 2021 – 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022 – 2033
- North America
  - Market Size and Forecast, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Dose Form, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
    - U.S.
    - Canada
- Latin America
  - Market Size and Forecast, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Dose Form, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Market Size and Forecast, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Dose Form, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Dose Form, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Market Size and Forecast, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Dose Form, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Market Size and Forecast, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Dose Form, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, By Country/Region, 2021 – 2033, (US$ Mn)
    - South Africa
    - Central Africa
    - North Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
  - Nabriva Therapeutics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Paratek Pharmaceuticals, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Melinta Therapeutics, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Allergan plc
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Bayer AG
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Lupin Pharmaceuticals, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Mylan N.V.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Sanofi S.A.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Pfizer Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Dainippon Sumitomo Pharma
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Takeda Pharmaceutical Company Limited
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Basilea Pharmaceutica International AG
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 42 market data tables and 26 figures on "Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market” - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

COMMUNITY ACQUIRED BACTERIAL PNEUMONIA (CABP) TREATMENT DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Table of Contents (Version-2026)

Research Objectives and Assumptions

Market Purview

Market Dynamics, Regulations, and Trends Analysis

Global Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market, By Drug Class, 2021 – 2033, (US$ Mn)

Global Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market, By Dose Form, 2021 – 2033, (US$ Mn)

Global Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market, By Route of Administration, 2021 – 2033, (US$ Mn)

Global Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market, By Distribution Channel, 2021 – 2033, (US$ Mn)

Global Community-acquired Bacterial Pneumonia (CABP) Treatment Drugs Market, By Region, 2021 – 2033, (US$ Mn)

Competitive Landscape

Section

EXISTING CLIENTELE

U.S. Office:

Menu

Reader Club

Help

Connect With Us :

Secure Payment By :